Yuanxin Technology
About Yuanxin Technology
Yuanxin Technology is a Digital Health startup based in Fengtai District, Beijing, China that has raised $971M in venture capital across 5 funding rounds since 2015. The company reached Pre-IPO stage in April 2018 with a $73M round led by Tencent. Yuanxin Technology's investor base includes 8 institutional funds, with HongShan (Sequoia China) leading the most recent equity round.
Beijing Yuanxin Technology Group (圆心科技) is an integrated healthcare platform founded in 2015 and headquartered in Beijing. Operating under the brand Miaoshou Doctor, Yuanxin connects patients, physicians, hospitals, pharmaceutical companies, and insurers through a unified digital ecosystem spanning online consultations, pharmaceutical distribution, and health insurance services. The company's Miaoshou Doctor platform is one of China's first licensed internet hospitals, serving over 40 million monthly active users with access to 1.3 million registered doctors. Yuanxin also operates a network of 264 Yuanxin Pharmacy locations across 30 provinces and provides digital hospital management services to over 200 hospitals nationwide. The company's 'hospital-patient-medication-insurance' model generated approximately $971 million in cumulative venture funding from investors including HongShan (Sequoia Capital China), Tencent, Qiming Venture Partners, INCE Capital, and OrbiMed. Yuanxin filed for its fifth Hong Kong Stock Exchange listing in 2026 at a reported $2.7 billion valuation.
Yuanxin Technology Funding Rounds Timeline
5 rounds · $971M raised · since 2015
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Series C | April 2018 | $73M | — | Tencent | Sequoia China, Qiming Venture Partners, Kunling Capital |
| Series C+ | January 2019 | $73M | — | Starquest Capital | Sequoia China |
| Series D | June 2020 | $85M | — | Sequoia China | Qiming Venture Partners, INCE Capital, CITIC Securities, Index VC |
| Series E | February 2021 | $465M | — | Sequoia China | Tencent, Qiming Venture Partners, CITIC Securities, CICC Capital |
| Series F | August 2021 | $231M | — | Sequoia China | B Capital Group, OrbiMed, INCE Capital, Springhill Fund, Kunling Capital |
Investors in Yuanxin Technology
8 institutional investors across 5 rounds
Lead investors
Co-investors
Recent news about Yuanxin Technology
Questions about Yuanxin Technology
How much has Yuanxin Technology raised?
Yuanxin Technology has raised $971M across 5 funding rounds since 2015.
Who are the investors of Yuanxin Technology?
Yuanxin Technology's investors include HongShan (Sequoia China), Tencent, Qiming Venture Partners, INCE Capital, OrbiMed, B Capital Group, CITIC Securities, Kunling Capital.
When was Yuanxin Technology's last funding round?
Yuanxin Technology's most recent round was a $73M Series C in April 2018, led by Tencent.
What is Yuanxin Technology's valuation?
Yuanxin Technology reached a $2.7B valuation (unicorn status) with its Series C round in April 2018.
Where is Yuanxin Technology headquartered?
Yuanxin Technology is headquartered in Fengtai District, Beijing, China, and was founded in 2015 by He Tao, Han Daoliang.